| Literature DB >> 27308634 |
Sandesh C S Nagamani1, Ayelet Erez2.
Abstract
Clinical observations in citrullinemia type I, an inborn error of metabolism, led us to explore the benefits of somatic ASS1 silencing in cancer. We found that downregulation of ASS1 results in preferential utilization of its substrate, aspartate, for pyrimidine synthesis to support cell proliferation. Reducing aspartate availability for pyrimidine synthesis restricted cancerous proliferation.Entities:
Keywords: Aspartate; argininosuccinate synthase; cancer metabolism; pyrimidine synthesis; urea cycle
Year: 2016 PMID: 27308634 PMCID: PMC4905422 DOI: 10.1080/23723556.2015.1127314
Source DB: PubMed Journal: Mol Cell Oncol ISSN: 2372-3556